Skip to content
Trial Eligibility
Menu

Exercise Testing After Preeclampsia

NCT06741436

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Though cardiovascular disease (CVD) is the leading cause of mortality in women, traditional epidemiology in this area has focused on later life, when cardiometabolic risk has already exacted a cumulative toll on the vascular system. Recent data from the investigators and others has highlighted pregnancy as a unique, early moment of cardiovascular stress in young women that may "unmask" CVD propensity. It is unclear if PreE simply represents a "failed stress test" or directly contributes to the pathophysiology of future CVD.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Preeclampsia
  • Heart Failure Preserved Ejection Fraction
  • Hypertension

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
Vanderbilt University Medical Center
Last updated on ClinicalTrials.gov
April 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Tennessee · 1

  • Vanderbilt University Medical Center · Nashville, TN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.